The etiology of atherosclerosis that occurs in diabetes mellitus is unclear. Previously, adenosine has been shown to inhibit growth of rat aortic smooth muscle cells. Nucleoside transporters play an integral role in adenosine function by regulating adenosine levels in the vicinity of adenosine receptors. Therefore, we studied the effect of 25 mM D-glucose which mimics hyperglycemia of diabetes, on adenosine transport in cultured human aortic smooth Pathologically, the increase in ENT1 activity in diabetes may affect the availability of adenosine in the vicinity of adenosine receptors and thus alters vascular functions in diabetes.
INTRODUCTION
Adenosine modulates cellular functions via G-protein-coupled receptors to protect cells and organs and is released in response to cell injury and stress. For instance, adenosine levels in blood and interstitial fluid increase during hypoxia and ischemia. Increased extracellular adenosine causes vasodilation by acting through A 2 adenosine receptors on vascular smooth muscle cells (SMCs) (5, 31) and thus increases blood flow and oxygenation. Adenosine inhibits platelet aggregation (33), decreases heart rate (14) and antagonizes the stimulatory effects of catecholamines (37). These important functions of adenosine as a negative feedback modulator of cell and organ energy demand and consumption and as a cell and organ protective agent make it known as "retaliatory metabolite" (25). Recent reports also showed that adenosine released during preconditioning by short periods of ischemia followed by reperfusion induces cardioprotection to a subsequent sustained ischemia (17) . This effect is mediated in part by activation of A 1 and A 3 adenosine receptors in cardiomyocytes, and involves PKC and mitochondrial K ATP channels (24).
Nucleoside transporters fine-tune the local concentrations of adenosine in the vicinity of adenosine receptors. Two major classes of nucleoside transporters in mammalian cells have been characterized by Na + dependence (16) . The equilibrative nucleoside transporters (ENTs) are facilitated-diffusion systems and are Na + -independent. They are further subdivided into two types on the basis of their sensitivities to inhibition by nitrobenzylmercaptopurine riboside (NBMPR) (4, 43) . ENT1 is potently inhibited by nanomolar concentrations of NBMPR but ENT2 is resistant to NBMPR up to 1 µM. Both ENT1 and ENT2 are broadly selective, accepting both purine and pyrimidine nucleosides but ENT2 also transports nucleobases such as hypoxanthine (6, 26, 46) . In contrast, the concentrative nucleoside transporters (CNTs) are Na + -dependent. CNT1 is pyrimidine-selective (36), CNT2 is purine-selective (42) while CNT3 is broadly selective (35, 41).
Diabetes mellitus is a major risk factor for cardiovascular diseases. Since adenosine inhibits growth of vascular SMCs, (10, 11, 12, 13) and nucleoside transporters are involved in adenosine homeostasis, in the present study, we characterized the nucleoside transport systems in cultured human aortic smooth muscle cells (HASMCs). We also determined the effect on adenosine transport of long-term exposure of cells to 25 mM D-glucose, a condition which mimics hyperglycemia of diabetes.
MATERIALS AND METHODS

Culture of HASMCs
HASMCs were obtained from American Tissue Culture Collection (Manassas, VA) and cultured in DMEM (containing 5 mM D-glucose) supplemented with 10% (v/v) fetal bovine serum, 100 U/ml penicillin, 100 µg/ml streptomycin at 37 o C in 95% air-5% CO 2 . All experiments were carried out with cells from passages 6-14. Forty-eight hours prior to uptake study and mRNA and protein isolation, cells were incubated in serum-free DMEM. To study the effect of D-glucose, 20 mM D-glucose was added to the medium for a final concentration of 25 mM. Under these conditions, there were no changes in cell number and morphology when the cells were grown in the presence of 5 mM (control) and 25 mM glucose (32).
Adenosine uptake
All experiments were carried out in HEPES-buffered Ringer solution containing (in 
RNA isolation and RT-PCR
Total RNA was isolated from HASMCs using TRIzol reagent (Invitrogen, Grand Island, NY). Two µg of total RNA were used for first strand cDNA synthesis using random hexamer primers and Superscript II RNase H -Reverse Transcriptase (SuperScript Preamplification System, Invitrogen). The resulting first strand cDNA was directly used for PCR amplification.
Sets of primers were designed and synthesized for PCR analysis. The two primers used for amplifying ENT1 (accession number AF079117) were 5'-GCAGCACCCTTGCCTGAG-3'
(sense) and 5'-GAAGGCACTTTCTGATAG-3' (antisense), which generated a 420base pair (bp) PCR product. The two primers for ENT2 (accession number AF029358) were 5'-ACAGCCAGGATCCTGAGC-3' (sense) and 5'-CATGGACAGGAGCATGGC-3' (antisense), which generated a 399bp product. The two primers for CNT1 (accession number NM_004212)
were 5'-ACCCCTCGAGACGAAGAG-3' (sense) and 5'-AAACAGAGCCAGGGCCCT-3' (accession number BC004324). The two primers for amplifying S16 were 5'-CCCGCTGCAGTCTGTGCAGGT-3' (sense) and 5'-CCAAACTTTTTGGACTCGCAG-3'
(antisense), which yielded a PCR product of 384bp.
Western blotting
Polyclonal anti-hENT1 antibody was raised in rabbit as previously described (18).
HASMCs were grown to confluence on 10-cm Petri dishes. All subsequent steps were conducted 
Statistical analysis
Adenosine uptake data were expressed as means ± S.E. 
RESULTS
Characterization of adenosine transport in HASMCs
The time course of [ 3 H]adenosine uptake (10 µM) in HASMC is shown in Fig. 1A . There was no difference between the Na + -dependent and Na + -independent [ 3 H]adenosine uptake. The Na + -independent [ 3 H]adenosine uptake was linear for up to 5 min and was completely inhibited by 0.5 mM NBMPR. We also compared the To test whether the adenosine transport was mediated by ENT1 and/or ENT2, the doseresponse of NBMPR inhibition of [ 3 H]adenosine transport was determined. The adenosine uptake was inhibited by NBMPR in a dose-dependent manner with an IC 50 value of 0.69 ± 0.05 nM and was completely abolished by 10 nM NBMPR (Fig. 1B ).
RT-PCR was used to confirm the expression of ENT1 in HASMCs (Fig. 2 ). As predicted, PCR product of ENT1 was amplified from RNA isolated from HASMCs. PCR product of ENT2 was also amplified although ENT2 activity was not functionally detected. There was no amplification of CNT1, CNT2 or CNT3 (Fig. 2) . These results complemented the functional studies that Na + -dependent adenosine transport was absent in HASMCs.
Effect of D-glucose on adenosine uptake in HASMCs
Diabetes is characterized with high blood D-glucose and it has recently been shown that expression of nucleoside transporters during diabetes is differentially regulated in different tissues and cell types (28, 29). Therefore, we studied the effect of 25 mM D-glucose on (Fig. 1B) , 3) ENT1 mRNA was found in HASMCs (Fig. 2) . Although ENT2 mRNA was revealed by RT-PCR, adenosine uptake study did not detect a functional ENT2 in HASMCs. This discrepancy might be due to a very low ENT2 expression level that was far below the detection threshold of functional study. We also demonstrated that 25mM Dglucose exerted a stimulating effect on adenosine transport in HASMCs (Fig. 3A) . This effect was due to an increase in ENT1 abundance in HASMCs and was supported by the increased mRNA and protein levels of ENT1 (Fig. 4) , as well as the increased number of high affinity Diabetes-induced changes in ENT1 expression are cell-specific. Unlike vascular SMCs, ENT1 expression in heart, liver and kidney of streptozotocin-induced diabetic rats are decreased (29) . Approximately 80% of the adenosine release from heart is derived from cardiomyocytes (8) and ENT1 is a major contributor to this adenosine efflux (29). Pawelczyk et al has suggested that down-regulation of ENT1 in the heart may decrease adenosine release and thus impair the regulation of vascular functions by adenosine and its ability to exert cardioprotective effect during ischemia and reperfusion (29). However, it is not clear whether the source of adenosine is intracellular or extracellular under stress conditions. Deussen et al (9) showed that in guinea pig hearts under well oxygenated conditions, addition of NBMPR increased interstitial adenosine concentrations and the source of adenosine was extracellular. An example of such a source is the hydrolysis of AMP by ecto 5'-nucleotidase (8) . In contrast to heart, endothelial cells and SMCs act as sinks in adenosine homeostasis by transporting extracellular adenosine into cells.
Interestingly, diabetes induces opposite changes in ENT1 activity and message in endothelial cells and SMCs. ENT1 expression is reduced in endothelial cells (28) but is increased in SMCs
freshly isolated from human diabetic umbilical vein (1) . In the present study, we also demonstrated that ENT1 in aortic SMCs is increased when the cells were grown under elevated glucose concentration. Taken together, the results suggest that there is a coordinated regulation of ENT1 in these cells.
The physiological consequence of increased ENT1 expression of diabetes in vascular functions remains to be determined. It has been reported that patients with diabetes mellitus suffer greater morbidity from ischemia (2). Therefore, increased ENT1 in vascular SMCs may 
